Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 489801 - 489820 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L04AC14) sarilumab (adm: P) | KEVZARA 150MG/1.14ML INJ | 1X2CT | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | SanofiAventisU.S.LLC |
| USA | (L04AC14) sarilumab (adm: P) | KEVZARA 150MG/1.14ML INJ | 1X2CT | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | SanofiAventisU.S.LLC |
| USA | (L04AC14) sarilumab (adm: P) | KEVZARA 150MG/1.14ML INJ,PEN,1.14ML | 2X1.14ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | SanofiAventisU.S.LLC |
| USA | (L04AC14) sarilumab (adm: P) | KEVZARA 150MG/1.14ML INJ,PEN,1.14ML | 2X1.14ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | SanofiAventisU.S.LLC |
| USA | (L04AC14) sarilumab (adm: P) | KEVZARA 200MG/1.14ML INJ | 1X2CT | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | SanofiAventisU.S.LLC |
| USA | (L04AC14) sarilumab (adm: P) | KEVZARA 200MG/1.14ML INJ | 1X2CT | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | SanofiAventisU.S.LLC |
| USA | (L04AC14) sarilumab (adm: P) | KEVZARA 200MG/1.14ML INJ,PEN,1.14ML | 2X1.14ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | SanofiAventisU.S.LLC |
| USA | (L04AC14) sarilumab (adm: P) | KEVZARA 200MG/1.14ML INJ,PEN,1.14ML | 2X1.14ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | SanofiAventisU.S.LLC |
| USA | (L04AC16) guselkumab (adm: P) | TREMFYA 100MG/ML INJ | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L04AC16) guselkumab (adm: P) | TREMFYA 100MG/ML INJ | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L04AC16) guselkumab (adm: P) | TREMFYA 100MG/ML INJ ONE PRESS INJECTOR | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L04AC16) guselkumab (adm: P) | TREMFYA 100MG/ML INJ ONE PRESS INJECTOR | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L04AC17) tildrakizumab (adm: P) | ILUMYA 100MG/ML INJ,SYRINGE,1ML | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | SunPharmaceuticalIndustries,Inc. |
| USA | (L04AC17) tildrakizumab (adm: P) | ILUMYA 100MG/ML INJ,SYRINGE,1ML | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | SunPharmaceuticalIndustries,Inc. |
| USA | (L04AC19) satralizumab (adm: P) | ENSPRYNG 120MG/ML INJ,SYRINGE,1ML | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Neuromyelitis Optica | GenentechUSA,Inc. |
| USA | (L04AC19) satralizumab (adm: P) | ENSPRYNG 120MG/ML INJ,SYRINGE,1ML | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Neuromyelitis Optica | GenentechUSA,Inc. |
| USA | (L04AC22) spesolimab (adm: P, course dose) | SPEVIGO 60MG/ML INJ,SOLN | 2 x 7.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AC22) spesolimab (adm: P, course dose) | SPEVIGO 60MG/ML INJ,SOLN | 2 x 7.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AC24) mirikizumab (adm: P) | OMVOH 20MG/ML INJ,SOLN | 15ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative | EliLilly&Company |
| USA | (L04AC24) mirikizumab (adm: P) | OMVOH 20MG/ML INJ,SOLN | 15ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative | EliLilly&Company |
Pages
